
Telix Pharmaceuticals Acquires ImaginAb for $73 Million to Expand Antibody Engineering Capabilities
Prime Highlights: Telix secures a US$45 million ($73 million) deal to acquire US-based antibody engineering

Prime Highlights: Telix secures a US$45 million ($73 million) deal to acquire US-based antibody engineering

Prime Highlights: DBAY Advisors, an asset management firm, has agreed to acquire UK-based Alliance Pharma

Prime Highlights: Medicare will now cover Eli Lilly’s Zepbound for obstructive sleep apnea, following FDA

Prime Highlights: ACG has inaugurated a cutting-edge capsule manufacturing facility in Rayong, Thailand, marking it

Prime Highlights: Mass General Brigham researchers developed a novel immunotherapy that prevents squamous cell carcinoma

Prime Highlights: Atogepant, appears to begin acting quickly, and the frequency of migraine attacks may

Prime Highlights: The European Commission has approved the combination of Rybrevant (amivantamab) and Lazcluze (lazertinib)

Prime Highlights: Pfizer UK, a subsidiary of Pfizer, has introduced a new therapeutic agent, sotatercept,

Merck gains global rights to Hansoh Pharma’s experimental oral weight loss drug, HS-10535. The milestone

The Cydem VT Automated Clone Screening System, a high-throughput microbioreactor platform for automated top clone